Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
Apply
MVX-220
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step